(Q43907196)

27 November 2017

title

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

1

1 reference

27 November 2017

6

Lawrence Corey

1 reference

27 November 2017

3

Michael Remington

1 reference

27 November 2017

2

David Carrell

1 reference

27 November 2017

Elizabeth Kexel

4

1 reference

27 November 2017

Judy Zeh

series ordinal

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

20 February 2002

1 reference

Clinical Infectious Diseases

27 November 2017

published in

1 reference

27 November 2017

volume

34

1 reference

27 November 2017

issue

7

1 reference

27 November 2017

page(s)

944-948

1 reference

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

27 November 2017

cites work

1 reference

Virologic characteristics of subclinical and symptomatic genital herpes infections

21 January 2018

1 reference

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group

21 January 2018

1 reference

A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections

21 January 2018

1 reference

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/339325

1 reference

27 November 2017

1 reference